News, Events & Resources
There’s a lot happening at Melinta. We are the company of the moment and enterprise of the future. Join us in realizing our vision — this is our story, and it’s going to be legendary.
Melinta Therapeutics Acquires U.S. Rights to TOPROL-XL® (metoprolol succinate) from New American Therapeutics
April 6, 2022Press ReleaseMelinta Therapeutics Acquires U.S. Rights to TOPROL-XL® (metoprolol succinate) from New American Therapeutics MORRISTOWN, N.J., Apr. 6, 2022 — Melinta Therapeutics, LLC...
Melinta Therapeutics Announces Appointment of Peter Piliero as Vice President of Medical Affairs
March 14, 2022Press ReleaseMelinta Therapeutics Announces Appointment of Peter Piliero as Vice President of Medical Affairs MORRISTOWN, N.J., Mar. 14, 2022 — Melinta Therapeutics, LLC...
Melinta Therapeutics President and CEO Christine Ann Miller Elected to Board of Directors of Iveric Bio
January 6, 2022Press ReleaseMelinta Therapeutics President and CEO Christine Ann Miller Elected to Board of Directors of Iveric Bio MORRISTOWN, N.J., Jan. 6, 2022 — Melinta Therapeutics, LLC...